ATLANT 3D EIS – Hero

ATLANT 3D EIS (ASA)

Don't invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Offer details View offer details & apply
Type: Single Company EIS (ASA)
Sector: Technology
Target return: 9.6x
Funds raised / sought: £10m / £10m
Minimum investment: £25,000
Next application deadline: 13 Nov 2026 for next close
Offer details View offer details & apply
Type: Single Company EIS (ASA)
Sector: Technology
Target return: 9.6x
Funds raised / sought: £10m / £10m
Minimum investment: £25,000
Next application deadline: 13 Nov 2026 for next close
Disclaimer What to expect post-investment
This deal has been arranged, reviewed and introduced by West Hill Capital. Please see the Important Notice in the Offer Document for the respective responsibilities of the Company and its Directors, and West Hill, which approved the document. West Hill and the Company are responsible for shareholder updates – expected once a year. The investment will be held by Aldbridge Services London, which is responsible for shareholder communications.

Important: EIS relief is not guaranteed. Advance assurance has not been obtained for this round and the Company’s historic EIS status is the subject of an unresolved appeal following HMRC’s withdrawal of relief for shares issued in 2022.

Backed by Sony: patented technology turning AI designs into physical materials with Apple, Google DeepMind, Meta and NASA as clients

The problem

AI is transforming materials discovery, but the physical infrastructure needed to turn those discoveries into usable materials has not kept pace. AI is estimated to identify around 100,000 candidate materials each year for applications including semiconductors, batteries, sensors and defence, yet fewer than 1% are ever physically realised.

Turning a computational prediction into a manufactured device currently involves eight separate hand-offs. Each stage is largely sequential and reliant on specialist equipment, with repeated transfers between machines, teams and organisations.
The result is a lengthy and expensive development cycle.

Validating a new material typically takes three to five years and costs an estimated €0.5-€2 million. As a result, bringing an advanced material from discovery to market can take 20 years or more.

ATLANT 3D believes this gap between discovery and commercialisation represents around €25 billion of lost innovation value each year.

ATLANT 3D’s solution

ATLANT 3D has developed an integrated system that it believes could cut the journey from AI-discovered material to manufacturable device from more than 10 years to less than one year, by combining material creation, testing, prototyping and data feedback in a continuous process.

The Company’s solution centres on its NANOFABRICATOR®, a family of programmable manufacturing systems that turn digital material designs into physical materials and devices for testing. The range includes LITE, designed for R&D and materials discovery; PRO, an industrial system built to semiconductor-industry standards; and ZERO-G, developed for space applications. Google DeepMind has acquired a LITE system for AI-driven materials discovery.

NANOFABRICATOR® systems use ATLANT 3D’s patented Direct Atomic Layer Processing (DALP®) technology to create material structures one atomic layer at a time. The process is controlled through digital instructions, providing precise control over which materials are deposited, where and in what structure.

According to the Company, DALP® is compatible with more than 450 material families, can cut process steps by up to 100-fold, deposit materials up to 100 times faster than conventional approaches and produce approximately 95% less chemical waste.

Importantly, each experiment can inform the next. ATLANT 3D’s software translates material targets from AI models and simulations into instructions for NANOFABRICATOR®, then feeds the experimental data into the next design. This creates a continuous cycle in which materials can be created, tested and refined, rather than moving repeatedly through a fragmented development process.

Why consider investing?

Since 2018, ATLANT 3D has progressed from developing its core technology to deploying systems, signing commercial contracts and building relationships with leading technology, semiconductor and aerospace organisations. It has also built a substantial IP portfolio and assembled deep scientific and industry expertise.

The opportunity

ATLANT 3D raised c.£25 million in equity funding, including investment from Sony and West Hill Capital, the introducers of this offer, alongside international private investors and angels. It has also secured more than £10 million in non-dilutive funding from the European Space Agency, EU Horizon programmes and the Danish government.

The Company is now planning a €250+ million Series B growth-equity round in the second half of 2027, expected to include tier-one investors – not guaranteed. 

Ahead of this, the Company is seeking to raise up to £10 million through an Advance Subscription Agreement (ASA) at a 25% discount to the planned Series B. The round has already received commitments of more than £10 million and has been extended following investor demand.

Wealth Club investors have a £1 million allocation, available on a first-come, first-served basis. The minimum investment is £25,000 (normally £50,000 through West Hill Capital).

The current round is also available through a Convertible Loan Note (CLN), offering a 20% conversion discount – see more details below.

The Company forecasts substantial growth as NANOFABRICATOR® sales scale. Revenue is projected to reach €9.1 million in 2027, with EBITDA profitability targeted for 2028 and positive cash flow for 2029. By 2031, the Company projects annual revenue of €590.5 million, generated from equipment sales and leasing, R&D and prototyping, consumables, and software and data subscriptions. These are ambitious forecasts – high risk and not guaranteed.

The directors do not currently expect to pursue an exit for at least three years. Potential routes thereafter include a trade sale to a larger technology Company or an IPO in the US or Europe, although neither is guaranteed. Based on the Company’s forecasts, the target return is 9.6x by 2031 (based on the ASA Longstop conversion price) – not guaranteed.

As can be expected when investing in a loss-making, early-stage business, the potential rewards are significant, but so are the risks. Please carefully read all investment documents prepared by West Hill Capital to form your own view. Please note, before completing an investment application, you will have to qualify as an Elective Professional Client of West Hill Capital.

Important: The information on this website is for experienced investors. It is not advice nor a research or personal recommendation to invest. If you’re unsure, please seek advice. Investments are for the long term. They are high risk and illiquid and can fall as well as rise in value, so you could get back less than you invest.

The deal at a glance

Type Single Company EIS (ASA)
Stage Pre-Series B
Date started trading 2018
Funding to date c.£25 million equity, £10m non-dilutive grants
Co-investors Sony, West Hill Capital investors, Diode Capital
Northern Universities Ventures Fund, angel investors
Sector Advanced materials / Deep tech
Fully diluted pre-money valuation c.£415 million (based on ASA long-stop conversion price)
Market size Est. €17 billion by 2030 (AI-enabled materials discovery, autonomous laboratories and atomic-scale manufacturing)
Business / revenue model Equipment sales and leasing, R&D services, recurring revenue from consumables, software, data and licensing
Revenue FY26 (Dec YE) €1.2m
Forecast revenue FY31* €590.5 million
EBITDA positive from* 2028
Target return*
9.6x in 2031, based on Company’s forecasts and ASA long-stop conversion price

* Forecast and not guaranteed.

Note: the Company is currently loss-making. Capital is at risk: you could lose your investment.

Risks – important

This is a single company offer with no diversification. It involves investing in an early-stage business, which is by nature high risk and prone to failure. There is a risk that the capital raised may not be sufficient to achieve the Company’s objectives. You could lose all the amount you invest.

Like all investments available through Wealth Club, it is only for experienced investors happy to make their own investment decisions without advice.

There is no ready market for unlisted EIS shares: they are illiquid and hard to sell and value. There will need to be an exit for you to receive a realised return on your investment. Exits are likely to take considerably longer than the three-year minimum EIS holding period; equally, an exit within three years could impact tax relief.

EIS relief is not guaranteed. Advance assurance has not been obtained for this round and the Company’s historic EIS status is the subject of an unresolved appeal following HMRC’s withdrawal of relief for shares issued in 2022.

Under the ASA, no EIS relief can be claimed until shares have been issued on conversion and the relevant EIS3 certificate has been received. There is no guarantee that HMRC will authorise the Company to issue EIS3 certificates. The CLN and shares issued on its conversion will not qualify for EIS relief. Tax treatment depends on individual circumstances and may change.

Before you invest, please carefully read the Information Memorandum which contains further details on the considerable risks – alongside the Wealth Club Risks and Commitments.

Private offer

Investors in this round will invest in ATLANT 3D Limited through an ASA or a CLN.

ASA terms overview

Under the terms of the ASA, shares will convert:

  • On the planned Series B: at a 25% discount to the Series B share price, provided the round raises at least £20 million and completes before the longstop date.
  • If the Series B or another qualifying funding round has not completed by the long-stop date: at £8.00 per share. The longstop date is currently estimated at 30 June 2027.

After taking tax advice, West Hill states the ASA is intended to qualify for EIS, but there is no guarantee that the Company or the shares issued on conversion will qualify, or that investors will receive EIS relief. Please read the EIS section of the offer document and take independent tax advice if unsure.

The £8.00 long-stop conversion price implies a pre-money valuation of c.£415 million. For comparison, the offer document’s selected group of AI materials discovery, nanotechnology and advanced manufacturing companies has a median valuation of £827 million, around 99% higher. This is a Company-selected peer comparison and does not indicate the valuation ATLANT 3D will ultimately achieve.

CLN terms overview

Under the terms of the Convertible Loan Note (CLN):

  • 8% annual interest accrues on the amount invested.
  • On the planned Series B: the loan and accrued interest convert into shares at a 20% discount to the Series B share price.
  • Maturity date: 31 December 2031.
  • Unsecured: the CLN is not secured against ATLANT 3D’s assets.
  • No EIS relief: shares issued on conversion of the CLN will not qualify for EIS tax relief.

Aldbridge Services London Limited will act as the custodian and administrator of this offer. 

All the services Wealth Club and, where applicable, its subsidiaries provide are governed by the Terms and Conditions of the Wealth Club Services.

Fees

Investors will pay no direct initial or ongoing charges to invest. Fundraising costs are being met by the Company. Please refer to the Schedule of Charges for more details. 

To invest, you will have to qualify as an Elective Professional Client of West Hill.

This financial promotion has been communicated and approved by Wealth Club Ltd on 9 November 2026

Wealth Club aims to make it easier for experienced investors to find information on – and apply for – investments. You should base your investment decision on the offer documents and ensure you have read and fully understand them before investing. The information on this webpage is a marketing communication. It is not advice or a personal or research recommendation to buy any of the investments mentioned, nor does it include any opinion as to the present or future value or price of these investments. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination.

opens in new window